본문 바로가기

Hybrid treatment of multilevel revascularization in patients with peripheral arterial disease a multi-centre study in Korea

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q3
저널
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE47(3) · pp.235 · 2018
피인용
Web of Science 6Scopus 10
FWCI (Scopus)
0.34
JCR IF
JCR 2017 1.21
ISSN
0301-1526

저자

  1. Lee, Soon Cheon제1저자Department of Surgery, Gwangyang Sarang Hospital, Gwangyang, South Korea
  2. Joh, Jin HyunDepartment of Surgery, Kyung Hee University, School of Medicine, Seoul, South Korea
  3. Chang, Jeong-HwanDepartment of Surgery, Chosun University, College of Medicine, Cheondam Medical Center, Gwangju, South Korea
  4. Kim, Hyung-KeeDepartment of Surgery, Kyungpook National University School of Medicine, Daegu, South Korea
  5. Kim, Jang YongDepartment of Surgery, Catholic University, College of Medicine, South Korea
  6. Park, Ki HyukDepartment of Surgery, Daegu Catholic University, College of Medicine, Daegu, South Korea
  7. Hong, Ki ChunDepartment of Surgery, Inha University, College of Medicine, Incheon, South Korea
  8. Byun, Seung JaeDepartment of Surgery, Wonkwang University, School of Medicine, Iksan, South Korea
  9. Lee, Tae SeungDepartment of Surgery, Seoul National University, College of Medicine, Seoul, South Korea
  10. 정혁재Research Institute for Convergence of Biomedical Science and Technology, Division of Vascular and EndoVascular Surgery, Department of Surgery, Pusan National University School of Medicine, Yangsan, South Korea
  11. 이상수교신저자Research Institute for Convergence of Biomedical Science and Technology, Division of Vascular and EndoVascular Surgery, Department of Surgery, Pusan National University School of Medicine, Yangsan, South Korea

초록

Background: Endovascular treatment is an alternative first-line management for peripheral artery disease (PAD). Hybrid treatment (HT) is defined as a combined treatment for patients with PAD using endovascular and open surgery, simultaneously performed in an operating room. The results of HT are reportedly good for multilevel revascularization (MR) in patients with chronic limb ischaemia, and even in older high-risk patients. The goal of this study was to examine the clinical and haemodynamic outcomes of HT in patients who need MR. Patients and methods: Nine university hospitals in Korea participated in this multicentre study. A total of 134 patients with multilevel PAD underwent HT and MR. Patients were enrolled from July 2014 to June 2015 and were followed for 18 months. Results: The mean age of the patients was 68.8 +/- 9.93 years and 88.1 % were men Patients with Rutherford category 2 to 3 and 4 to 6 comprised 59.0% and 42.0% of the group, respectively. The technical success rate was 100%. The primary patency rates at 12 and 18 months were 77.6% and 63.9%, respectively The primary-assisted patency rates at 12 and 18 months were both 90.0%. The pre-operative mean ankle brachial index (0.43 +/- 0.23) increased to 0.87 +/- 0.23 at six months post-operatively (t-test, p<0.05). The amputation free survival rate was 97.1%. Conclusions: Although outcomes of multilevel PAD are reportedly poor when endovascular treatment alone is used, we have shown that HT is a feasible alternative modality for patients with multilevel PAD, with satisfactory amputation-free survival and freedom from re-intervention rates.

키워드

Hybrid treatmentmultilevel revascularizationperipheral arterial diseaseOCCLUSIVE DISEASERISK-FACTORSVASCULAR-DISEASEPREVALENCEENDARTERECTOMYTHERAPY

식별자

Scopus EID
2-s2.0-85046013610
WoS UID
000434122300009